Drug intelligence / Profile preview

N-anthracen-2-yl-5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-7-amine

Development stage: Unknown
Modality: Small Molecules

Overview

N-anthracen-2-yl-5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-7-amine is a synthetic small molecule belonging to the anthracene and triazolopyrimidine chemical classes. It has a molecular formula of C20H15N5 and an average molecular weight of 325.37 g/mol. The compound is primarily studied as an experimental agent in drug discovery research and has not been approved for clinical use or any therapeutic indication. Its structure features an anthracene moiety linked to a methylated triazolopyrimidine core. There are no reported clinical trials or approved indications for this compound as of now; its mechanism of action and biological targets remain uncharacterized in public databases.[1][3][6][9]

Other names: N-(2-Anthryl)-5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-7-amine

Beyond the preview

Go deeper on N-anthracen-2-yl-5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-7-amine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on N-anthracen-2-yl-5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-7-amine.

Explore the full profile